knowledge -WSS

knowledge

author：hotspot 2025-08-26 03:42:34 - browse：689

Photo illustration of Covid 19 testing swabs on a blue background. — Timothy Stenzel led the FDA's diagnostics division during the Covid-19 pandemic, as the agency scrambled to push through and validate accurate Covid tests. Adobe

Timothy Stenzel, the federal regulator who led the Food and Drug Administration’s diagnostics division during the chaotic time of Covid-19 pandemic, has left the agency. The FDA confirmed Thursday that Stenzel, who led the FDA’s office of in vitro diagnostics, retired at the end of 2023.

During the early days of the pandemic, Stenzel was in the middle of a turf battle between the Centers for Disease Control and Prevention and the FDA over the regulation of Covid tests. At one point, the CDC made Stenzel wait at its facility overnight after he arrived for a meeting on Covid test development, Politico reported at the time.

It was a hectic time. Testmakers rapidly introduced new Covid-19 screening products with little data, as it was a brand new virus. The pandemic especially laid bare FDA’s inability to control lab-developed tests (LDTs). Many of the Covid-19 PCR tests fell in this category. Early on, using powers granted by the public health emergency, the FDA required labs to apply for emergency use authorization. But a STAT investigation found that the Department of Health and Human Services told the FDA to stop this measure, despite knowing that many of the tests may have been inaccurate.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： ‘Oppenheimer’ and the risks of AI in health care

WSS

EQRx, failed developer of low

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Vertex Pharmaceuticals may move headquarters in Boston

There's no autism epidemic. It's an autism diagnosis epidemic

No plane should take off without an EpiPen onboard

Scientists boost immune system in aging mice by making it youthful

focus

knowledge

explore

Bright Health sells Medicare Advantage business to Molina

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Virginia high school admissions case could be legal follow

Covid vaccine financial winners and losers, from Pfizer to Novavax

BioMarin wins approval for gene therapy to treat hemophilia A

NIH launches clinical trials and new research office for long Covid

After affirmative action ruling, medical educators look to 'holistic review'

What the US credit downgrade means for the economy, your finances

How to save PrEP access — and even expand it

New safety details link Apellis eye drug to rare cases of blindness

leisure time

What the US credit downgrade means for the economy, your finances

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Lawsuit alleges UnitedHealth Group unit illegally denied claims

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

explore

leisure time

knowledge

leisure time